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ABSTRACT: Alpha-synuclein (αSyn) forms amyloid 
fibrils in the neurons of Parkinson’s disease (PD) 
patients’. Despite a role for Cu2+ in accelerating αSyn 
fibril formation, coupled with reports of copper dis-
homeostasis in Parkinson’s disease (PD), there remain 
controversies surrounding the coordination geometry of 
Cu2+ with αSyn.  Here we compare visible circular 
dichroism (CD) spectra of Cu2+ loaded on to full-length 
αSyn together with four peptides that model aspects of 
Cu2+ binding to the N-terminus and Histidine50 of αSyn. 
Using glycine as a competitive ligand, the affinity of Cu2+ 
for full-length αSyn is determined to have a conditional 
dissociation constant, at pH 7.4, of 0.1 nM.  A similar 
affinity of 0.3 nM is determined for the tri-peptide MDV 
that mimics the N-terminus of αSyn, while the 
incorporation of a putative histidine side-chain in the N-
terminal complex facilitates the formation of a macro-
chelate with the histidine, which results in an increase in 
the affinity for Cu2+ to 0.03 nM at pH 7.4. Comparisons 
of the visible absorbance and CD spectra over a range of 
pH values also indicates that the MDV tripeptide closely 
models Cu2+ binding to full-length αSyn and rules out a 
role for His50 in the primary Cu2+ binding complex of 
monomeric αSyn. However, there are reports that 
suggest His50 does form a macro-chelate with the N-
terminal Cu2+ complex; we reconcile these conflicting 
observations by identifying a concentration dependence 
of the interaction. Only at the higher concentrations can 
the imidazole nitrogen bind to the N-terminal Cu2+ to 
from a ternary complex, rather than via a macrochelate. 
This work shows even for this intrinsically disordered 
protein a large macro-chelate with Cu2+ is not favored. 
Understanding Cu2+ coordination to αSyn gives a more 
complete picture of its place in amyloid assembly and 
cytotoxicity 
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INTRODUCTION:  
Parkinson’s disease (PD) is the second most prevalent neurodegenerative disorder after 
Alzheimer’s disease. PD is marked by the loss of dopaminergic neurons in the brain’s substantia 
nigra, along with the presence of subcellular protein accumulations, known as Lewy bodies. 
These Lewy bodies are comprised of amyloid fibrils of the protein alpha-synuclein (αSyn). 
Furthermore, some early onset inherited forms of PD are associated with single point mutations 
within αSyn, for example: A53T; A30P; E46K; H50Q 1. Metal ions, and in particular copper 
ions, have been linked with PD through the observation of increased Cu2+ concentrations in the 
cerebrospinal fluid of PD patients 2, while those with chronic exposure to copper in industry have 
an increased risk of developing PD 3.  
αSyn is largely found intracellularly at presynaptic terminals in the reducing environment of 
the cytosol where copper ions are predominantly Cu+. There have been a number of studies of 
Cu+ coordination to αSyn 4a , 4b , 4c.  In addition, Cu ions are capable of redox cycling between 
Cu+ and Cu2+ which can lead to hydroxyl radical production and other reactive oxygen species, a 
hallmark of PD 5. Indeed, hydroxyl radical production by copper redox cycling can cause 
dityrosine formation in αSyn, which can affect amyloid assembly 6. A proportion of αSyn is 
secreted by neuronal cells extracellularly 7 which highlights the importance of Cu2+ binding to 
αSyn. 
The coordination of Cu2+ can affect the structure and self-assembly of αSyn. The change in 
charge may affect the self-association, while Cu2+ coordination can affect the amyloid assembly 
pathway 8 and structural morphologies (strain) of the amyloids fibrils 9 . Cu2+ has been proposed 
as a trigger for the misfolding and assembly of αSyn in Parkinson’s disease (PD) as Cu2+ can 
accelerate αSyn fibril formation in vitro  8, 9c, 10. Cu2+ has also been shown to exacerbate toxicity 
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of oligomeric αSyn in cell cultures 9b, 9c  . It is for these reasons much effort has been directed at 
characterizing the coordination and affinity of Cu2+ binding to αSyn, for reviews see 4b, 4c, 11 .  
Visible CD is a powerful probe of coordination in metal ion-protein complexes. The 
coordination of Cu2+ via amide main-chain chelation generates CD signal in the d-d electronic 
absorption bands, known as the vicinal effect. The sign of the signal is very sensitive to the 
coordination geometry 12. One advantage Vis-CD has over visible absorption spectra is that the 
non-protein bound metal ion is typically CD silent. As a consequence, determination of the 
stoichiometry, coordination geometry and pH dependence of metal ion binding is not 
complicated by signal from the free metal ion 10a, 13.  
αSyn is 140 residues in length and is intrinsically disordered in an aqueous environment. 
Paramagnetic broadening by Cu2+ of 1H-15N HSQC NMR spectra of full-length αSyn identified 3 
regions of the protein that interact with Cu2+ ions. These were centered at the N-terminus; His50 
and Asp121  10a, 14 ,  although paramagnetic broadening by Cu2+ can be caused by weak transient 
Cu2+ binding.  Numerus studies have now shown the locus of the primary binding site for Cu2+ to 
be the N-terminal amino group 4b . These include spectroscopic  15 16 and potentiometric studies 
15b  16d of peptide models and comparisons with full-length αSyn. It has been suggested that αSyn 
binds Cu2+ ions through two different modes; solely at the N-terminal residues MDV, see Figure 
1a 15 or  alternatively, via the N-terminal residues together with the imidazole of histidine at 
position 50 to form a macro-chelate complex, Figure 1b 16. While model peptides of the N-
terminus (MDV), together with free imidazole, have been shown to form a ternary Cu2+ complex 
at high pH 17. Post-translational modifications of αSyn where the N-terminus becomes acetylated 
have been reported 18 19.  Although quantitation is difficult, the acetylation of the N-terminus is 
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believed to be quite wide spread, but is not thought to be universal. The primary binding site for 
Cu2+ for acetylated αSyn is centered at His50 not at the N-terminal residues 20. 
We aim to build on the large body of work surrounding the coordination of Cu2+ to αSyn, and 
resolve some of the controversies surrounding the role of His50 in the primary N-terminal 
binding site. To investigate the influence of the side chains, Asp2 and His50, on Cu2+ binding to 
the N-terminus of αSyn, four peptides models were generated: (i) αSyn(1-3) (MDV-am); (ii) 
αSyn(1-3D2A) (MAV-am);  (iii) αSyn(ac46-52) (ac-EGVVHGV-am); and (iv) αSyn(1-7,46-52) 
(MDVFMKGEGVVHGV-am). The affinities, visible-CD, absorption spectrum and pH 
dependence of coordination and are directly compared with Cu2+ binding to full-length αSyn.  
We show the affinity, pH dependence, absorbance and visible-CD spectra for full-length, αSyn is 
most similar to that of the tri-peptide MDV, and the histidine side-chain at position 50 does not 
coordinate to the primary Cu2+ binding site in full-length αSyn by forming a macro-chelate. 
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EXPERIMENTAL  
 
Expression and Purification of αSyn: 
αSyn was expressed and purified as previously described 21. Briefly the protein was expressed 
in E. coli using plasmid pT7-7 21 .  After transforming in BL21 (DE3)-gold cells (Agilent 
Technologies, Santa Clara, USA), αSyn was obtained by growing the bacteria in LB at 37 °C 
under constant shaking at 250 rpm and supplemented with 100 μg.ml-1 ampicillin to an OD of 
0.6.  The expression was induced with 1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) at 
37 °C for 4 h, and the cells were harvested by centrifugation at 6200 g (Beckman Coulter, Brea, 
USA). The cell pellets were re-suspended in lysis buffer (10mM Tris-HCl pH 8, 1 mM EDTA 
and EDTA-free complete protease inhibitor cocktail tablets obtained from Roche, Basel, 
Switzerland) and lysed by sonication. The cell lysate was centrifuged at 22,000 g for 30 min to 
remove cell debris. In order to precipitate the heat-sensitive proteins, the supernatant was then 
heated for 20 min at 70 °C and centrifuged at 22,000 g. Subsequently streptomycin sulfate was 
added to the supernatant to a final concentration of 10 mg.ml-1 to stimulate DNA precipitation. 
The mixture was stirred for 15 min at 4°C followed by centrifugation at 22,000 g. Then, 
ammonium sulfate was added to the supernatant to a concentration of 360 mg .ml-1 in order to 
precipitate the protein. The solution was stirred for 30 min at 4°C and centrifuged again at 
22,000 g. The resulting pellet was re-suspended in 25 mM Tris-HCl, pH 7.7 and dialyzed against 
the same buffer in order to remove salts. The dialyzed solutions were then loaded onto an anion 
exchange column (26/10 Q sepharose high performance, GE Healthcare, Little Chalfont, UK) 
and eluted with a 0–1 M NaCl step gradient, and then further purified by loading onto a size 
exclusion column (Hiload 26/60 Superdex 75 preparation grade, GE Healthcare, Little Chalfont, 
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UK). All the fractions containing the monomeric protein were pooled together and concentrated 
by using Vivaspin filter devices (Sartorius Stedim Biotech, Gottingen, Germany). The purity of 
the aliquots after each step was analyzed by SDS-PAGE and the protein concentration was 
determined from the absorbance at 275 nm using an extinction coefficient of 5600 M-1 cm-1.  
 
Peptides and Proteins: 
Peptides were purchased from Generon Ltd (Maidenhead, UK).  F-moc chemistry was used to 
synthesize the various model peptides. All peptides were C-terminally amidated in order to 
mimic the continuation of the peptide sequence in the larger protein. The peptides were removed 
from the resin and de-protected before purification to a single elution band by reverse-phase 
HPLC. The samples were characterized using mass spectrometry. 
Peptides with amidated C-termini (am) and free N-terminal amino groups studied included 
MDV, MAV, ac-EGVVHGV (with acetylated N-terminus; αSyn(ac46-52)) and 
MDVFMKGEGVVHGV; a designed sequence based on α-synuclein residues 1-7 and 46-52; 
αSyn(1-7,46-52).  
 
UV-Visible Absorption spectroscopy:  
UV-Visible electronic absorption spectra of the Cu2+ complexes were acquired using a Hitachi 
U-3010 spectrophotometer using a 1 cm path-length (l) quartz cuvette.  Spectra were acquired 
between 200-800 nm with a wavelength scan speed of 60 nm mins-1.  Absorption spectra were 
smoothed using a 6 nm window and adjusted for concentration (c);  = Abs/(c  l) . 
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Circular Dichroism (CD): 
Typically, CD spectra were recorded at 25° C on an Applied Photophysics Chirascan 
instrument between 260 and 800 nm, with sampling points every 2 nm, using a 1 cm pathlength 
cell. Typically, three scans were recorded and averaged, baseline spectra subtracted from each 
spectrum, followed by smoothing using a window of 6 nm. Data were processed using Applied 
Photophysics Chirascan Viewer, Microsoft Excel and the KaleidaGraph spreadsheet / graph 
package. The molar ellipticity Δ (M-1cm-1), spectra were obtained through conversion of the 
direct CD measurements (θ, in millidegrees), using the relationship Δ  = θ/(c * l * 33,000), 
where c is the molar concentration and l is the path-length.  
 
Titrations: 
All chemicals were purchased from Sigma-Aldrich at the highest purity available and UHQ 
water was used throughout (10-18 Ω-1cm-1 resistivity). Small aliquots of fresh 20 mM aqueous 
solutions (Cu2+ as CuCl2.2H2O,) and glycine were used for titrations. Typically ethylmorpholine 
buffer (20 mM) was used in measurements presented in figures 2, 3, 4 and S1.  While pH 
dependence spectra, Figure 5 and also Figure 6, S2-S7 were recorded in the absence of a buffer.  
The pH was adjusted with µl additions of 0.05 mM NaOH or HCl.  pH was maintained to within 
0.05 of a pH unit. The pH was measured before and after acquiring each spectrum.  The 
lyophilized weight of each peptide was used to estimate the concentration, assuming 20 % 
moisture content. However, it was the known concentration of metal ions at sub-stoichiometric 
levels to the peptide that was used for the conversion to molar ellipticity. 
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Affinity measurements: 
Glycine, the competing Cu2+ chelator used in calculating the affinity of the Cu2+-peptide 
complexes, forms a Cu(Gly)2 complex when bound to Cu
2+. The individual conditional affinities 
of each glycine binding event (Ka1 and Ka2), at pH 7.4, are 7.4x10
5 and 7.4x104 M-1 
respectively22. 
The concentration of Gly required for equal mole equivalents of Cu2+ to be bound to both 
peptide and glycine is used to determine the affinity (conditional dissociation constants) at pH 
7.4 of Cu2+ for the protein using equation 1. The “free” Cu2+ refers to the concentration of Cu2+ 
not bound to either glycine or peptide. 
Kd = [Cu
2+
free]=
[Cu2+total]-[Cu
2+
bound to peptide]
1+(Ka1[Glyfree])+(Ka1Ka2([Glyfree]
2
))
     
 (Equation 1) 
Where; Cu2+ bound to peptide is equal to total Cu2+ (at θ = 0.5) divided by 2 and [Gly
free
]= 
[Gly
total
]-[Gly
bound to Cu
2+]. 
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RESULTS: 
Cu2+ affinity of αSyn and peptide models 
The Cu2+ affinity of the four peptides which model aspects of Cu2+ coordination to αSyn have 
been studied. The affinities have been determined at pH 7.4 using glycine as a competitive ligand 
and directly compared to full-length αSyn (Figure 2, Table 1). The amount of glycine needed to 
compete Cu2+ from the αSyn peptides can be used to calculate the affinity by monitoring the 
Visible-CD signal of Cu2+ bound to the αSyn peptides. This approach has the advantage of 
directly monitoring the coordination of Cu2+ to the model peptides, while the Cu(Gly)2 complex 
is CD-silent, and has a known affinity for Cu2+. We note, there is no shift in wavelength of the 
absorption bands upon addition of glycine which indicates a ternary complex is not favored, and 
so glycine is a direct competitor for Cu2+.  The difference in affinity for the four peptide models 
is quite marked. In particular, 8.5 molar equivalents of glycine, is required to remove half of the 
Cu2+ from MDV tri-peptide (Figure 2a) while only 1.2 molar equivalents of glycine are required 
to remove half of the Cu2+ from MAV (Figure 2b).  Using equation 1 (see experimental) a 
conditional dissociation constant (Kd) at pH 7.4 can be calculated. Cu
2+ affinities for the various 
peptide models are summarized in Table 1. The conditional dissociation constants, at pH 7.4, 
range between 30 pM and 18 µM.  Notably, the Cu2+ complex at the N-terminus involving Asp2 
and chelation from histidine imidazole is an order of magnitude tighter, at 0.03 nM compared to 
the N-terminal tripeptide complex MDV, 0.3 nM.  In contrast, the peptide which contains just 
His50 as a residue with a Cu2+ coordinating sidechain, has an affinity for Cu2+ six orders of 
magnitude weaker with a Kd of 18 µM.  
The Cu2+ affinities for the 4 peptide models can be directly compared to full-length αSyn, 
Figure 2e. The affinity for full-length αSyn is slightly tighter than that of the tri-peptide MDV, 
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0.3 nM, compared to 0.1 nM for full-length αSyn, while the peptide containing a histidine to 
form a macro-chelate has an affinity 3 times tighter (0.03 nM) than full-length αSyn. To 
summarize, the Cu2+ affinity for full-length αSyn is closest in magnitude to two model peptides; 
MDV and the macro-chelate complex MDV with the additional histidine residue, Table 1. 
 
 
Table 1. Comparison of Cu2+ binding affinities and wavelength absorption properties for αSyn 
and model peptides  
 
Protein/peptide Kd at pH 7.4 λ max absorption λ max CD 
αSyn(1-140) 0.1 nM 628 nm (pH 5.5 - 9) 610 nm (+) 
 
MDV 0.28 nM 628 nm (pH 5.5 - 9) 618 nm (+) 
    
αSyn(1-7,46-52) 0.03 nM       605 nm (pH 7.5 - 9) 
628 nm (pH 5.5) 
570 nm (+) (pH 7.5 - 9) 
     610 nm (pH 5.5) 
 
MAV 36 nM  555 nm (-) 
 
αSyn(ac46-52) 18000 nM               590 nm 525 nm (+) 
 
Kd are conditional dissociation constant, at pH 7.4, spectra reported at pH 7.4 unless stated. 
 
 
 
Visible Absorbance and CD Spectra 
Next we compared the visible absorbance spectra and visible-CD spectra of the model peptides 
to full-length αSyn. The difference in Cu2+ coordination geometries is reflected in the visible 
absorbance spectra shown for Cu2+ loaded at 0.9 mol equivalents, at pH 7.4, Figure 3a. In 
particular, an increase in the number of coordinating nitrogens in the Cu2+ tetragonal complex 
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will result in absorbance maxima at shorter wavelengths, for the d-d electronic transitions. For 
example, absorbance bands range between 540 nm for the 4N complexes to 765 nm for a 1N3O 
complex 23. This behavior is observed for the αSyn model peptides; the MDV Cu2+ complex has 
been shown to form a 2N2O complex (Figure 1a) and has an absorption band centered at 630 
nm, as would be predicted, while the macro-chelate complex αSyn(1-7,46-52), which forms a 
3N1O coordination (Figure 1b) is shifted to shorter wavelengths and has an absorption maximum 
at 605 nm, see Fig 3a. The absorption spectrum of full-length αSyn is almost identical to that of 
the absorbance spectrum for MDV, Figure 3a.   
Visible-CD spectra are very sensitive to coordination geometry around Cu2+ and so can give 
additional information beyond the visible absorbance spectra, whilst not being complicated by 
signal from the presence of unbound Cu2+ 10a, 13. The visible-CD spectra of all four peptides are 
shown in Figure 3b,c, loaded with 0.9 mol-equivalents of Cu2+ at pH 7.4, and compared with 
full-length αSyn. The MDV analogue, with an Asp2Ala substitution, has marked effects on the 
CD spectra, causing an inversion of the vis-CD spectra for the d-d electronic transition, as 
previously reported 15a. Although not identical, the spectrum of αSyn has the closest similarity 
with MDV, with CD bands centered at 610 and 625 nm respectively, Fig 3c. The visible-CD 
spectrum of αSyn(1-7,46-52) which can form the macro-chelate with the histidine side-chain also 
has similarities to full-length but like the absorption spectrum the CD band is shifted to a shorter 
wavelength, with a visible-CD maxima at 570 nm. The CD signal of the αSyn(ac46-52) model 
peptide is very different with a positive CD band at 540 nm. The CD absorbance bands observed 
are also summarized in Table 1. 
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Stoichiometry of Cu2+ Coordination 
To further probe the Cu2+ coordination to the model peptides, Cu2+ has been loaded on to the 
peptides beyond 1 mole equivalent.  Titration of Cu2+ on to MDV and MAV at pH 7.4 shows a 
clear 1:1 stoichiometry with fixed CD bands, centered at 612 and 555 nm, respectively, that 
increase in intensity until saturation at 1 mole equivalent, shown in Supplemental Figure S1a,b. 
Similarly, the αSyn(ac46-52) peptide also forms a 1:1 complex with a single set of CD signal at 
520 nm and 320 nm (Supplemental Figure S1c).  In contrast, the Cu2+ binding properties of 
αSyn(1-7,46-52) are more complicated with a CD band at 573 nm that increases in intensity up 
to one molar equivalent of Cu2+, this CD band then reduces a little in intensity while a CD band 
centered at 543 nm appears, Figure 4a. Addition of a second Cu2+ ion shifts the CD band towards 
a shorter wavelength of 543 nm, this change in wavelength maxima in the CD spectra between 1 
and 2 mole equivalents of Cu2+ is shown as an insert in Fig 4a.  We postulated that the macro-
chelate complex composed of the N-terminus and histidine is replaced by two separate 
complexes at two equivalents of Cu2+, with the two separate complexes centered at MDV and 
His50, as previously suggested 17.   This possible behavior is strongly supported by simulated 
data presented in Figure 4b, here the spectrum of αSyn(1-7, 46-52) with two equivalents of Cu2+ 
can be very closely mimicked by the direct combination of two individual CD spectra of MDV 
and αSyn(ac46-52) at 1 equivalent, as shown in Figure 4b. This Cu2+ titration indicates the 
coordination geometry is sensitive to changes in Cu2+ stoichiometry with loss of the macro-
chelate at supra-stoichiometric equivalents. 
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pH dependence of Cu2+ binding: histidine coordination is lost at low pH. 
The pH dependence of Cu2+ binding to the MDV tripeptide and αSyn(1-7,46-52) are shown in 
Figure 5. These are highlighted because they have the most similar CD, absorbance spectra and 
affinity to full-length αSyn, which is also shown in Figure 5.  Figure 5a-c shows visible 
absorption spectra while Fig 5d-f shows the complementary visible-CD spectra over a range of 
pHs in the presence of 1 mol-equivalent of Cu2+. A single set of visible-CD bands for MDV 
remain very stable over a range of pHs (between pH 5-10), there is no indication of a shift to 
other coordination geometries with an increase in pH. The mid-point of Cu2+ complex formation 
occurs at a relatively low pH of 4.6 for MDV (Figure 5a). It is clear that the Asp has a significant 
stabilising influence on the complex even at relatively low pH values, as previously described 
15a.  
The behavior of αSyn(1-7, 46-52) coordination is more complex. At pH 7 and above the 
visible absorption spectra are consistent with a 3N1O geometry which has an absorbance 
maximum at 600 nm.  Below pH 7 the absorbance maxima shifts to longer wavelengths from 
600 to 630 nm, Figure 5b, which is consistent with 2N2O coordination. This shift to longer 
wavelengths at lower pH values is echoed in the Visible-CD spectra which shifts from 605 to 
630 nm for the CD bands, Figure 5e. The αSyn(1-7, 46-52) visible-CD bands below pH 6 adopt 
the same appearance as the MDV tripeptide. This suggests a change in coordination from 3N1O 
complex (pH 7.0) to a 2N2O complex at lower pH (pH 5.5). This behavior indicates the loss of 
the macro-chelate imidazole ligand between pH 5.5-7.  The pH dependence spectra of full-length 
αSyn resembles much more closely the behavior of MDV than the αSyn(1-7,46-52) peptide. In 
particular, there is no marked-shift in absorbance maximum between pH 7 and 5.5. Like the 
MDV tripeptide the absorbance bands remains centered at 630 nm over the whole range of pHs 
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for full-length αSyn. This is strong evidence to rule out any significant role for coordination by 
His50 in full-length αSyn Cu2+ complex even at high pH. 
The pH dependent Vis-CD spectra of Cu2+ complexes for MAV is shown as supplemental 
data, Figure S2, and is very different from the behavior of full-length αSyn. In the case of MAV, 
which lacks aspartate, the Vis-CD spectra suggests a complete loss of amide Cu2+ coordination 
below pH 7, with a mid-point at pH 7.5. This type of pH dependence for MAV is similar to the 
tripeptide AAA 12b. The αSyn(ac46-52) Cu2+ complex is also very pH sensitive with the loss of a 
CD active complex below pH 6 implying a loss of amide main-chain coordination, Supplemental 
Figure S2b. 
 
Concentration dependence of imidazole chelation to the N-terminal Cu2+ complex 
Our absorption and visible CD data indicates the His50 does not bind to the N-terminal Cu2+ 
complex in full-length αSyn, and yet there are two quite careful studies using multi-pulse EPR to 
indicate His50 does coordinate in full-length αSyn 16a 16b. We wondered how these conflicting 
observations could be reconciled. We postulated the differences observed might be related to the 
differences in experimental conditions. In particular, the EPR spectra were acquired at much 
higher concentrations in the presence of the cryo-protectant glycerol. We questioned if the 
glycerol might impact the αSyn structure and its ability to form a macro-chelate. We therefore 
obtained visible-CD and absorbance spectra of Cu2+ loaded αSyn in the presence of 25% (v/v) 
glycerol. Comparison of the absorption spectra and visible-CD indicate glycerol does not affect 
the coordination of the Cu2+, see Supplemental Figure S3, which rules this out as an explanation 
of the conflicting binding modes reported. 
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Next, we determined whether higher concentrations (350 µM) used in the EPR experiments 
could explain the different behavior.  Full-length αSyn is poorly soluble so it was not possible to 
study using optical spectroscopy, however  it was possible to use the more soluble MDV model 
peptide over a range of concentrations between 500 µM (used in the EPR experiments) to 100 
µM used here in the visible absorption/CD experiments.  We studied the ternary complex of 
MDV: Cu2+: αSyn(ac46-52) (1:1:1) over a range of concentrations  A clear concentration 
dependence of the wavelength maxima in both the visible-absorption and visible-CD spectra is 
observed, Figure 6.  We also show a very similar concentration dependent behavior for the 
mixture of MDV: Imidazole: Cu2+ (1:1:1), shown as supplemental Figure S4.  The impact of 
imidazole on the Cu-MDV visible absorption spectra are also shown in supplemental Figure S5. 
This ternary 3N1O complex with imidazole has previously been described 17.  Our spectra 
indicate, the more concentrated the (1:1:1) mixture, the more the absorbance bands shifted to 
shorter wavelengths. The shift to shorter wavelengths at higher concentrations suggests an 
increase in the extent of nitrogen (imidazole) equatorial chelation as the water oxygen is 
displaced. The concentration dependent behavior of the ternary complex, Figure 6 and S4, gives 
an explanation for the differing reports of His50 involvement in the N-terminal complex of full-
length αSyn.   
To confirm a role for the imidazole chelation of Cu2+ at higher concentrations control 
experiments were performed with MDV and Cu2+ only.  As expected the spectra shows no 
concentration dependent behavior, supplemental Figure S6.  We also performed concentration 
dependent measurements for αSyn(1-7,46-52), supplemental Figure S7.  This peptide exhibits 
absorbance bands typical for a 3N1O complex over all concentrations.  This concentration 
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independent behavior supports the assertion that αSyn(1-7,46-52), with just 12 amino acids 
between the histidine and the N-terminus, forms a macro-chelate rather than a ternary complex. 
 
DISCUSSION: 
To resolve controversies surrounding Cu2+ coordination to αSyn we have compared affinity, 
visible absorbance, visible CD, and pH dependence behavior for full-length αSyn to that of a 
series of model peptides. Taking this data together, the peptide model that most closely mimics 
Cu2+ binding to full-length αSyn is that of the simple tripeptide MDV, Figure 7a. The lack of pH 
dependence changes of full-length αSyn for visible absorbance and visible CD spectra rules out 
the formation of the complex with His50. In contrast, αSyn(1-7,46-52) does have imidazole 
nitrogen coordination at pH 7.4 which begins to be lost at pHs below 7 and is completely lost by 
pH 5.5, Figure 7b. The different behavior of αSyn(1-7,46-52) model peptide compared to full-
length αSyn can be explained by the considerable reduction in the number of residues between 
the N-terminus and the Histidine to just 12 residues in the model peptide. This facilitates 
histidine sidechain coordination in the N-terminal complex. We show here that higher pHs and 
sub-stoichiometric ratios of Cu2+ will promote the macro-chelate in the model peptide αSyn(1-
7,46-52), however even under these conditions our data indicates the His50 macro-chelate does 
not form for full-length αSyn. The visible absorption spectra are essentially identical for Cu2+ 
bound to MDV and full-length αSyn over the entire pH range 5-9. There are however subtle 
differences in the Cu2+ Vis-CD spectra, these may reflect very small differences in the 
conformation of the main-chain in the plain of the copper complex 12, caused by the presence of 
the additional 140 residues, rather than differences in the coordinating ligands. The involvement 
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of His50 (at 100 µM αSyn) can be ruled out as there are no pH dependent changes in 
coordination between pH 5.5 and 7. 
So why have some studies reported His50 involvement in the primary N-terminal Cu2+ 
complex? There are two key studies using EPR and full-length αSyn that suggest this 
involvement 16a, 16b. Drew et al points to a mixture of both 3N1O and 2N2O coordination 
geometries  (Figure 1a and 1b) in approximately equal proportions at pH 7.4 16a. Their relative 
proportions are likely to be pH sensitive, indeed, an EPR study at pH 6.5 indicates a single set of 
EPR signals for the 2N2O complex 15a. An explanation for the different observations compared 
to the data presented here, simply arises from the experimental condition, when acquiring EPR 
spectra. In particular the EPR spectra are acquired at 350 µM of αSyn, these high concentrations 
favor displacement of the water with His50 imidazole from a second αSyn molecule, Figure 7c. 
This assertion is supported by the concentration dependent behavior of the model ternary system, 
(MDV + αSyn(ac46-52) + Cu2+ ), shown in Figure 6. Only at the higher concentrations can the 
imidazole displace the water. This concentration dependent behavior can explain the change in 
coordination from 2N2O at low concentration to 3N1O at higher concentration. This also 
suggests that rather than full-length αSyn forming a macrochelate, whose formation would be 
independent of concentration, the His50 coordination is derived from a second αSyn molecule 
only favored at higher concentrations. 
We note that in full-length αSyn, His50 is covalently linked to the N-terminus, this will 
increase the ‘effective concentration’ of His50 close to the N-terminus in this intrinsically 
disordered protein. However, this is not sufficient to overcome the significant ordering necessary 
to form the macrochelate across 50 residues. Only by raising the actual concentration of αSyn 
can coordination by His50 take place from a second αSyn molecule coordinating to the N-
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terminal Cu2+ complex forming a ternary complex, rather than the formation of a macrochelate, 
Figure 7c. Our data indicates that at 100 µM and below the proportion of His50 chelation at the 
N-terminal Cu2+ complex will be minimal.  Although the 3N1O complex (ternary or macro-
chelate) could also be present in small amounts, at physiological concentrations the 2N2O 
complex dominates (Fig 1a).  
Others have described His50 involvement at pH 6.5 16c,  we suggest that in this case 
interpretation of the data is incorrect.  The study points to a 2N2O Cu2+ complex as seen in the 
MDV complex, but suggests that the nitrogen ligand is from His50 rather than the N-terminal 
amino group 16c. This type of complex is extremely unlikely; there is a large body of evidence for 
αSyn, along with many other Cu2+ protein complexes that point to the N-terminal amino group 
anchoring Cu2+ complexes 24. In particular, acetylation of the N-terminal amino group 
completely removes the strong coordination mode from αSyn 20.   
The concentration dependent behavior we have identified suggests that at physiological 
concentrations of αSyn, His50 will not bind at the N-terminal complex, however self-association 
of αSyn might favor the ternary Cu2+ complex formation. This in turn will influence the αSyn 
fibril assembly pathway 8 and morphology9a, 9b. Recent high resolution cryo-EM structures of 
αSyn indicate that the His50 is distant from the N-terminus in the final fibril structures reported 
25 even when you consider bridging ternary Cu2+ complexes between two αSyn molecules in the 
fibril structure. 
The affinity of Cu2+ for αSyn is an important determinant of the physiological relevance of the 
interaction. Cu+ is tightly chaperoned and regulated within the cytosol while Cu2+ is more weakly 
bound extra-cellularly and it is believed Cu2+ reaches levels of 15 micromolar 26, some have 
reported even higher fluxes of Cu2+ at the synapse, from 20-250 micromolar, during neuronal 
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depolarization 27. The 0.1 nM affinity (Kd) determined here for αSyn is therefore sufficiently 
tight to bind extracellular levels of Cu2+. 
The affinity measured here of 0.1 nM conditional dissociation constant for full-length αSyn at 
pH 7.4 (and for MDV 0.28 nM) is in agreement with a number of studies on full-length αSyn 
using a range of techniques: 0.2 nM at pH 7.4 28;  0.1 nM at pH 7.4 16b; and  0.4 nM at pH 7.0 5b. 
Others have reported affinities weaker than the 0.1 nM 15a, 29 but none have suggested an affinity 
(Kd) as tight as 0.03 nM observed for the model peptide αSyn(1-7,46-52) which can form the 
macro-chelate with Histidine. This further supports our assertion that Histidine50 does not 
stabilize the primary Cu2+ binding site in monomeric αSyn.   
The affinity for our acetylated peptide containing a single histidine, αSyn(ac46-52) has been 
determined to have a Kd of 18 µM at pH 7.4, which is in agreement with other reports  
30. This 
peptide represents a model for Cu2+ binding to full-length acetylated–αSyn.  The N-terminally 
acetylated peptide has a Cu2+ affinity five orders of magnitude weaker than non-acetylated αSyn. 
 
Conclusion 
We have shown that free imidazole or His50 within αSyn will only displace water as a ligand 
to the N-terminal Cu2+ complex at high (>350 µM) concentrations. This concentration dependent 
behavior gives an explanation for the seemingly conflicting observations made regarding the role 
of His50. Our studies show that, although αSyn is intrinsically disordered, forming a large 
macrochelate is not favored. Cu2+ coordination to the N-terminus together with His50 only takes 
place at higher, non-physiological, concentrations (used in EPR measurements) which results in 
a ternary complex, Figure 7c.  
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Cu2+ coordination to αSyn and its N-terminal acetylated form has been shown to accelerate 
fibril assembly 8, 10.  Cu2+ binding to the N-terminus can also impact the assembly pathway 8, 
fibril morphology 9a, 9b, 9c and cytotoxicity 9b, 9c of αSyn. How changes in metal homeostasis can 
impact the development of Parkinson’s Disease is still an open question 2-3. We still have much 
to discover surrounding the role of physiological metal ions in the amyloid assembly, redox 
chemistry and cytotoxicity of αSyn and other amyloidogenic proteins. 
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TOC: 
Copper2+ Binding to α-Synuclein.  Histidine50 can form a ternary complex with Cu2+ at 
the N-terminus but not a macrochelate. 
 
Copper may impact α-Synuclein neurotoxicity in Parkinsons Disease. We have compared 
affinity, visible absorbance, visible circular-dichroism and pH dependence behavior for full-
length α-Synuclein to that of a series of model peptides. We resolve a long standing controversy 
surrounding the role of His50 in Cu2+ coordination to α-Synuclein. We show that a ternary 
complex which involves the Cu2+ at the N-terminal and His50 only forms at higher 
concentrations, while a macrochelate is not favoured.  
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